SynthesisPharmacoEconomics2018

Systematic Review of the Costs and Benefits of Prescribed Cannabis-Based Medicines for the Management of Chronic Illness: Lessons from Multiple Sclerosis.

Samuel Herzog et al.PubMed ↗Publisher ↗

No numbers read from the abstract.